Genitope Corp (NASDAQOTH:GTOP)

PotatoCapital (24.13) Submitted: 12/19/2007 11:01:03 PM : Start Price: $4.03 GTOP Score: -94.20

We have a runner!

barnesa13 (< 20) Submitted: 11/27/2007 4:20:03 PM : Start Price: $4.64 GTOP Score: -95.94

Approval of MyVax

jogger21 (< 20) Submitted: 11/21/2007 10:06:57 AM : Start Price: $4.49 GTOP Score: -96.73

The phase 3 trial results will be available by year end 2007. Past results have shown a cure rate for cancer in excess of 42%. If phase 3 results are the same as phase 2, the FDA will approve. Technonogy should also work on other forms of cancer. Look for buy out by major biotech company if results are good.

tharlow (31.04) Submitted: 8/22/2007 3:26:08 AM : Start Price: $3.80 GTOP Score: -95.19

Bigger than Dendreon.

nguyenvanh (< 20) Submitted: 6/29/2007 5:24:15 PM : Start Price: $3.89 GTOP Score: -92.12

Phase III data out end of Q4.

indexmagnet (35.12) Submitted: 5/14/2007 5:46:19 PM : Start Price: $3.75 GTOP Score: -92.62

MyVax approval in Q4

n00bs (< 20) Submitted: 5/3/2007 4:38:37 PM : Start Price: $3.85 GTOP Score: -92.59

spekulative buy!
charts looks good
possible FDA autorizing

nojpokey (56.93) Submitted: 2/27/2007 1:23:23 PM : Start Price: $3.99 GTOP Score: -98.25

A litttle bit of a gamble but if they get FDA approval for their patient specific cancer treatments that will not only be a major breakthrough in new technology cancer treatment but a nice little profit. Monoclonal antiboties seem to another one of the quickly developing cancer therapies. So, two things going for them I take a chance....Isn't that half the fun?

sftechnology (< 20) Submitted: 12/8/2006 9:31:03 AM : Start Price: $3.30 GTOP Score: -99.31

An $11 stck for $3.25